SOBRE ESTE EPISÓDIO
Professor Francesco Del Galdo and Professor Yannick Allanore discuss two recent studies advancing the treatment landscape in scleroderma. This episode discusses tofacitinib efficacy and neutrophil-driven vasculopathy in SSc. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of scleroderma care.
To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
Inglês
Estados Unidos da América
TRANSCRIÇÃO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de Scleroderma Forum.
OUTROS EPISÓDIOS NESTE PODCAST
Join Professors Francesco Del Galdo from the University of Leeds, and Chris Denton from UCL, as they discuss the role of autoantibodies in scleroderma.
Join Professors Francesco Del Galdo and Elisabetta Renzoni, Doctor Elizabeth Volkmann and Clinical Nurse Specialist Jean Scopes as they discuss the key takeaways from our recent 'Harnessing the Power of the Multidisciplinary Team in Scleroderma' webinar.
Join Professors Francesco Del Galdo, Christopher Denton and Yannick Allanore as they discuss the key takeaways from our recent 'The Role of Autoantibodies in SSc' webinar.
Join Professors Francesco Del Galdo and Zsuzsanna McMahan as they review their highlights of the recent ACR 2025 congress, watch them discuss their abstracts and highlight key information.
Aviso: O podcast e a arte incorporada nesta página são de Scleroderma Forum, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.
